183 related articles for article (PubMed ID: 26872611)
1. MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients.
Reyes-Gibby CC; Wang J; Silvas MR; Yu R; Yeung SC; Shete S
BMC Genet; 2016 Feb; 17():40. PubMed ID: 26872611
[TBL] [Abstract][Full Text] [Related]
2. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
Van Allen EM; Lui VW; Egloff AM; Goetz EM; Li H; Johnson JT; Duvvuri U; Bauman JE; Stransky N; Zeng Y; Gilbert BR; Pendleton KP; Wang L; Chiosea S; Sougnez C; Wagle N; Zhang F; Du Y; Close D; Johnston PA; McKenna A; Carter SL; Golub TR; Getz G; Mills GB; Garraway LA; Grandis JR
JAMA Oncol; 2015 May; 1(2):238-44. PubMed ID: 26181029
[TBL] [Abstract][Full Text] [Related]
3. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
5. KIT polymorphisms were associated with the risk for head and neck squamous carcinoma in Chinese population.
Hang D; Yuan H; Liu L; Wang L; Miao L; Zhu M; Du J; Dai J; Hu Z; Chen N; Shen H; Ma H
Mol Carcinog; 2017 Jan; 56(1):232-237. PubMed ID: 27186940
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population.
Miao L; Wang L; Yuan H; Hang D; Zhu L; Du J; Zhu X; Li B; Wang R; Ma H; Chen N
Tumour Biol; 2016 Mar; 37(3):4169-74. PubMed ID: 26490987
[TBL] [Abstract][Full Text] [Related]
7. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.
Ock CY; Son B; Keam B; Lee SY; Moon J; Kwak H; Kim S; Kim TM; Jeon YK; Kwon SK; Hah JH; Lee SH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):873-83. PubMed ID: 26677030
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
9. Search for mutations in signaling pathways in head and neck squamous cell carcinoma.
De Carvalho TG; De Carvalho AC; Maia DC; Ogawa JK; Carvalho AL; Vettore AL
Oncol Rep; 2013 Jul; 30(1):334-40. PubMed ID: 23670291
[TBL] [Abstract][Full Text] [Related]
10. Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.
Jorge-Nebert LF; Zhang G; Wilson KM; Jiang Z; Butler R; Gluckman JL; Pinney SM; Nebert DW
Hum Genomics; 2016 Nov; 10(1):39. PubMed ID: 27894333
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
13. Effects of potentially functional polymorphisms in suppressor of cytokine signaling 3 (SOCS3) on the risk of head and neck squamous cancer.
Hang D; Yin Y; Wang L; Yuan H; Du J; Zhu M; Dai J; Chen N; Hu Z; Shen H; Ma H
J Oral Pathol Med; 2017 Sep; 46(8):598-602. PubMed ID: 27977878
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma.
Kawakita D; Oze I; Hosono S; Ito H; Watanabe M; Yatabe Y; Hasegawa Y; Murakami S; Tanaka H; Matsuo K
J Epidemiol; 2016 Jun; 26(6):292-9. PubMed ID: 26804037
[TBL] [Abstract][Full Text] [Related]
16. Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.
Nichols AC; Black M; Yoo J; Pinto N; Fernandes A; Haibe-Kains B; Boutros PC; Barrett JW
BMC Pharmacol Toxicol; 2014 Nov; 15():66. PubMed ID: 25428177
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer.
Lee WT; Huang CC; Chen KC; Wong TY; Ou CY; Tsai ST; Yen CJ; Fang SY; Lo HI; Wu YH; Hsueh WT; Yang MW; Lin FC; Hsiao JR; Huang JS; Chang JY; Chang KY; Wu SY; Lin CL; Wang YH; Weng YL; Yang HC; Chang JS
Oral Dis; 2015 Mar; 21(2):207-15. PubMed ID: 24724948
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H
BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888
[TBL] [Abstract][Full Text] [Related]
19. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
[TBL] [Abstract][Full Text] [Related]
20. [Association between genetic variants in microRNA biosynthesis genes and the risk of head and neck squamous cell carcinoma].
Yuan WW; Hang D; Wang LH; Chen SH; Ding ZX; Hu ZB; Ma HX
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1069-73. PubMed ID: 27539334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
